ALUR

Allurion Technologies

Stock NYSE – Stock Market Prices, News & Analysis

Allurion Technologies Inc specializes in non-invasive medical solutions for weight loss, including a non-surgical inflatable gastric balloon.

$ 1.24
0.79 %

Allurion Technologies

$ 1.24
0.79 %
ALUR

Allurion Technologies Inc specializes in non-invasive medical solutions for weight loss, including a non-surgical inflatable gastric balloon.

Price history of Allurion Technologies
Price history of Allurion Technologies

Performance & Momentum

6 Months 45.23 %
1 Year 69.30 %
3 Years 99.58 %
5 Years 99.56 %
Momentum
79

Strategic Analysis

Allurion Technologies • 2026

Allurion Technologies Inc positions itself in the healthcare sector with an innovative offering of non-invasive solutions for weight loss, centered around an inflatable gastric balloon that requires no surgery. This specialization in less invasive medical devices addresses a growing demand for alternatives to bariatric surgery.

Strengths
  • Innovation in non-invasive medical treatment for obesity
  • Response to a specific niche with strong societal potential
  • Business model focused on less risky and more accessible solutions than surgery
Weaknesses
  • Still an immature model with weak financial performance
  • Lack of visible commercial momentum in the short and medium term
Momentum

The neutral to negative momentum, combined with significant declines over longer periods, reflects a critical phase for the company. This calls for caution among retail investors, who will need to wait for tangible signs of operational recovery or a new commercial dynamic before considering a repositioning.

Analysis performed 3 days ago

Similar stocks to Allurion Technologies

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone